Simulations Plus is a healthcare company with over 25 years of experience translating science into user-friendly software and providing expert consulting to support drug discovery, clinical development research, and regulatory submissions.
Their approach to drug discovery is unique and innovative. They provide validated machine learning, QSP, QST, HTPK, PBPK, and PBBM modeling and simulation software for novice and expert users alike. Their software is designed to predict more than 100 important PK and ADMET properties for every hit, including unrivaled pKa prediction, bioavailability, as well as synthetic difficulty.
They have also jointly received a Phase I NIH-funded SBIR grant to predict the safety of large molecules such as proteins that are increasingly used to treat diseases.